Business
CardioComm Solutions to Release Gems(TM) Home Rx, A HeartCheck(TM) ECG Based, Low Cost ECG/Arrhytmia Monitoring Solution for Physicians and Medical Services
TORONTO, ON / ACCESSWIRE / October 26, 2015 / CardioComm Solutions, Inc. (TSXV: EKG) ("Cardi...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"CardioComm Solutions to Release Gems(TM) Home Rx, A HeartCheck(TM) ECG Based, Low Cost ECG/Arrhytmia Monitoring Solution for Physicians and Medical ServicesTORONTO, ON / ACCESSWIRE / October 26, 2015 / CardioComm Solutions, Inc. (TSXV: EKG) (\"CardioComm Solutions\" or the \"Company\") a global medical provider of consumer heart monitoring and medical electrocardiogram (\"ECG\") software solutions, today confirmed the scheduled November release of \"GEMS(TM) Home Rx\" which will enable low cost ECG and arrhythmia monitoring for physicians, health professional and ECG service providers.\nGEMS(TM) Home Rx is the newest software release from CardioComm Solutions and combines technologies from the Company's HeartCheck(TM) ECG devices cleared for consumer and prescription use and their GEMS(TM) based medical/hospital software. GEMS(TM) stands for global electrocardiogram (\"ECG\") management solution (GEMS(TM)) \nThe expected cost for an annual license of GEMS(TM) Home Rx will be $500 USD per year. The software will permit an unlimited number of ECGs to be imported and interpreted and will retain the option to allow for ECGs to be uploaded to the Company's SMART Monitoring ECG service if and when it is needed. Both the HeartCheck(TM) ECG PEN and the HeartCheck(TM) ECG Monitor will be supported by GEMS(TM) Home Rx.\nGEMS(TM) Home Rx is a Windows PC based software program that can allow for the collection of ECG recordings from HeartCheck(TM) ECG devices for viewing, reviewing, reporting and interpretation by qualified health care professionals and physicians. GEMS(TM) Home Rx is an ultra-lite prescription version of the Company's FDA, Health Canada and European Union compliant GEMS(TM) WIN software which is used by physicians, hospitals and medical call centers for ambulatory, trans-telephonic, wireless event and mobile cardiac telemetry ECG/arrhythmia monitoring of patients outside the hospital environment. GEMS(TM) Home, a consumer based, non-ECG analyzing version of GEMS(TM), was first released when the Company launched the HeartCheck(TM) ECG PEN. The HeartCheck(TM) ECG PEN is a personal, single ECG lead, hand-held, Class II medical device cleared for consumer over-the-counter (\"OTC\") use in Canada and the USA.\nWhat changed with GEMS(TM) Home Rx vs GEMS(TM) Home? The Company confirms that there is a market segment that was unabl...